Association for Research in Vision and Ophthalmology

SEATTLE — In this video from the ARVO meeting, Jay Chhablani, MD, discusses data on pan-VEGF blockers and tyrosine kinase inhibitors for age-related macular degeneration.

SEATTLE — In this video from the ARVO meeting, Jay Chhablani, MD, discusses the advancement of AI technology to help predict the progression of age-related macular degeneration and geographic atrophy.

SEATTLE — In this video, Eleonora M. Lad, MD, PhD, vice chair of ophthalmology clinical research at Duke Health, discusses a presentation at the ARVO meeting on retinal pigment epithelium cells in age-related macular degeneration.

Catch up on the top Healio Video Perspectives from this year’s Association for Research in Vision and Ophthalmology meeting.

As Healio’s coverage of the Association for Research in Vision and Ophthalmology meeting winds down, catch up on this year’s most popular articles.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Mark R. Barakat, MD, discusses post hoc findings on IOP in patients receiving aflibercept 8 mg for diabetic macular edema in the PHOTON trial.

SEATTLE — Receiving travel support may help patients with age-related macular degeneration undergo more injections, regardless of the distance needed to travel for treatment, according to research presented at the Association for Research in Vision and Ophthalmology meeting.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Sean D. Adrean, MD, discusses data on aflibercept 8 mg vs. aflibercept 2 mg for the treatment of diabetic macular edema at 1 year.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Michael H. Goldstein, MD, of Aurion Biotech discusses studies exploring the use of human corneal endothelial cells for corneal edema secondary to endothelial dysfunction.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, George O. Waring IV, MD, FACS, discusses the Tecnis Odyssey’s tolerance to refractive error.